Movement Alert|Hims & Hers Health Inc. Intraday Decline 5.02%, Post-earnings pressure persists as FTC lawsuit expands

Market Focus11-16

On November 16, Hims & Hers Health Inc. saw an Intraday Decline of 5.02% in Regular Trading, trading at $19.0399 per share with turnover of $38.1441 million.

The move followed continued pressure from weaker-than-expected third-quarter results, softer fourth-quarter and full-year revenue guidance, and an expanded FTC lawsuit adding five states as co-plaintiffs.

In the latest quarter, the company reported a loss of $0.14 per share versus expectations for a $0.06 profit, while revenue rose to $890.4 million but missed consensus near $893.1 million. Hims & Hers Health Inc. guided fourth-quarter revenue to $875 million-$895 million, below expectations of about $953.8 million, and projected full-year revenue of $3.13 billion-$3.15 billion versus consensus near $3.21 billion. The amended FTC complaint alleges improper sharing of sensitive health information and misleading billing and subscription-cancellation practices, adding further overhang to sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment